Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shirizym is a branded generic pharmaceutical formulation marketed by MetaneX Life Science, an Indian pharmaceutical company based in Thane, Maharashtra. It is distributed as an oral syrup (Shirizym Syrup). Based on standard regional naming conventions, formulations with the suffix '-zym' typically represent digestive enzyme supplements containing fungal diastase and pepsin, which are utilized to aid digestion and relieve symptoms of indigestion, flatulence, and dyspepsia. However, because it is a marketed generic product rather than a novel drug candidate, detailed clinical development data, molecular targets, and specific active ingredient ratios are not documented in standard clinical trial registries.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shirizym.